Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Erlotinib Hydrochloride × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT00977548 2013-09-16

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Phase 2 Completed

39 enrolled 10 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Myelodysplastic Syndromes

Clinical Trials

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Erlotinib Study for Myelodysplastic Syndrome (MDS)